Project Grant F31DA059264
Award Date
9/12/24
Completion Date
7/31/24
Dollars Obligated
$174K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Irvine, CA 92697, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to advance understanding of the molecular mechanisms by which the histone methyltransferase enzymes G9A and GLP contribute to the development of addictive behaviors. The $272,395 award, effective from April 15, 2025 to March 31, 2027, will fund research at the University of California, San Francisco (UCSF) to: 1) Determine the molecular structure and...
The National Institute on Drug Abuse (NIDA) awarded a $492,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Chicago. This 5-year grant aims to elucidate the genetic and epigenetic mechanisms underlying cocaine addiction using a multidimensional approach. The key objectives are: 1) Conduct high-resolution chromatin accessibility and DNA methylation profiling to delineate cell-type and circuit-specific epigenetic configurations following...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $121,323 to the University of North Carolina at Chapel Hill to investigate the structural and functional responses of nucleus accumbens microglia following long-access cocaine self-administration in male and female rats. The research aims to: 1) explore morphological responses of accumbens microglia and evidence of astrocyte membrane...
The National Institute on Drug Abuse (NIDA) awarded a $249,236 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to Duke University to study the role of chromatin regulation and brain-derived neurotrophic factor (BDNF) in cocaine craving and addiction. The research aims to define the changes in chromatin architecture and gene expression in dopamine neurons of the ventral tegmental area that occur after forced abstinence from chronic cocaine use, and to test the requirement...
This federal Project Grant award of $180,646 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to investigate the molecular mechanisms underlying the regulation of cocaine drug-seeking behavior by astrocytic CREB. The principal investigator will build an independent research program to elucidate the transcriptional and epigenetic regulation of astrocytes in the context of drug abuse and addiction. Key...
This $1,127,388 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to determine the role of the small molecule Rac1 in neuronal ensembles governing cocaine-seeking behavior. The University of Florida is the primary awardee, with the overall objective to examine how Rac1 signaling impacts the behavioral, structural, and activity characteristics of neurons associated with cocaine-seeking. The...
This Project Grant award, titled "DIFFERENTIAL ROLES OF PREFRONTAL CORTICAL INTERNEURONS IN DRUG SEEKING AFTER WITHDRAWAL," is funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,478,199 award will support research at the University of California, San Diego (UCSD) to investigate the role of different interneuron types in the infralimbic cortex during cocaine self-administration and drug-seeking behavior after...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $118,656.00 to the Ponce Medical School Foundation Inc. in Puerto Rico. The project aims to investigate the neurophysiological changes in the prelimbic cortex and nucleus accumbens core caused by a traumatic event and cocaine exposure, and how those changes may increase vulnerability to cocaine use disorder. The study will assess the...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under CFDA Program 93.279 "Drug Use and Addiction Research Programs," provides $711,875 to the University of Massachusetts Medical School (UMass Medical) to explore the role of the neuropeptide nociceptin in suppressing cocaine reward. The 2-year project from June 2024 to May 2026 will leverage cutting-edge viral and genetic tools to characterize nociceptin signaling in the nucleus accumbens and its...
This National Institute on Drug Abuse (NIDA) Project Grant award under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to elucidate the corticolimbic circuit and neuroimmune mechanisms underlying the comorbidity of HIV and cocaine use disorders (CUDs). The $157,568 award, effective from November 13, 2024 to June 30, 2026, will be used by Drexel University to conduct a series of studies in male and female mice. The researchers will employ circuit-specific optogenetics to stimulate...